FIELD: medicine, ophthalmology.
SUBSTANCE: invention relates to the treatment of optic neuropathy in patients with edematous exophthalmos. For this, the drug mixture is introduced into the lymphatic region of the orbit by performing pterygopalatine blockades, daily, alternating between the right and left orbits. In this case, 3-4 injections are carried out using a drug mixture containing 20-40 mg of lidocaine, 3000-5000 IU of hemaze, 4-8 mg of dexazone, and 3-4 injections with a drug mixture containing 20-40 mg of lidocaine, 3000- 5000 IU of hemaz, and 4.0-8.0 mg of xefocam. In addition, patients undergo daily nasal electrophoresis with a 0.1% solution of the Semax drug, a course of 6-8 procedures.
EFFECT: method provides effective treatment with minimal side effects due to the complex effect on various pathogenetic links of the disease.
3 cl, 2 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ENDOCRINE OPHTHALMOPATHY TREATMENT | 2020 |
|
RU2725861C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF VASCULAR GENESIS | 2011 |
|
RU2452436C1 |
METHOD FOR TREATING PATIENTS FOR RECURRENT UVEITIS | 2005 |
|
RU2299065C1 |
METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
METHOD FOR TREATING THE CASES OF POST-INFLAMMATION BULLOUS KERATOPATHY | 2002 |
|
RU2218896C1 |
METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
METHOD FOR TREATING THE CASES OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS AFTER CATARACT EXTRACTION AND ARTIFICIAL EYE LENS IMPLANTATION | 2005 |
|
RU2290203C1 |
METHOD FOR COMPLEX TREATMENT OF ENDOGENOUS UVEITIS FOLLOWED BY MACULAR EDEMA | 2016 |
|
RU2635083C1 |
METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
Authors
Dates
2021-02-03—Published
2020-07-22—Filed